Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Cystine-glutamate transporter SLC7A11 mediates resistance to geldanamycin but not to 17-(allylamino)-17-demethoxygeldanamycin.

Liu R, Blower PE, Pham AN, Fang J, Dai Z, Wise C, Green B, Teitel CH, Ning B, Ling W, Lyn-Cook BD, Kadlubar FF, Sadée W, Huang Y.

Mol Pharmacol. 2007 Dec;72(6):1637-46. Epub 2007 Sep 17.

PMID:
17875604
3.

Lactoperoxidase-catalyzed activation of carcinogenic aromatic and heterocyclic amines.

Gorlewska-Roberts KM, Teitel CH, Lay JO Jr, Roberts DW, Kadlubar FF.

Chem Res Toxicol. 2004 Dec;17(12):1659-66.

PMID:
15606142
4.

Potential chemoprotective effects of the coffee components kahweol and cafestol palmitates via modification of hepatic N-acetyltransferase and glutathione S-transferase activities.

Huber WW, Teitel CH, Coles BF, King RS, Wiese FW, Kaderlik KR, Casciano DA, Shaddock JG, Mulder GJ, Ilett KF, Kadlubar FF.

Environ Mol Mutagen. 2004;44(4):265-76.

PMID:
15468054
5.

Formation and reduction of aryl and heterocyclic nitroso compounds and significance in the flux of hydroxylamines.

Kim D, Kadlubar FF, Teitel CH, Guengerich FP.

Chem Res Toxicol. 2004 Apr;17(4):529-36.

PMID:
15089095
6.

Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression.

Coles BF, Morel F, Rauch C, Huber WW, Yang M, Teitel CH, Green B, Lang NP, Kadlubar FF.

Pharmacogenetics. 2001 Nov;11(8):663-9.

PMID:
11692074
7.

In vitro bioactivation of N-hydroxy-2-amino-alpha-carboline.

King RS, Teitel CH, Kadlubar FF.

Carcinogenesis. 2000 Jul;21(7):1347-54.

PMID:
10874013
8.

Detoxification of carcinogenic aromatic and heterocyclic amines by enzymatic reduction of the N-hydroxy derivative.

King RS, Teitel CH, Shaddock JG, Casciano DA, Kadlubar FF.

Cancer Lett. 1999 Sep 1;143(2):167-71.

PMID:
10503898
9.

Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.

Culp SJ, Roberts DW, Talaska G, Lang NP, Fu PP, Lay JO Jr, Teitel CH, Snawder JE, Von Tungeln LS, Kadlubar FF.

Mutat Res. 1997 Aug 1;378(1-2):97-112.

PMID:
9288889
10.

Chemoprotection against the formation of colon DNA adducts from the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat.

Huber WW, McDaniel LP, Kaderlik KR, Teitel CH, Lang NP, Kadlubar FF.

Mutat Res. 1997 May 12;376(1-2):115-22.

PMID:
9202746
11.

Metabolic activation of aromatic amines by human pancreas.

Anderson KE, Hammons GJ, Kadlubar FF, Potter JD, Kaderlik KR, Ilett KF, Minchin RF, Teitel CH, Chou HC, Martin MV, Guengerich FP, Barone GW, Lang NP, Peterson LA.

Carcinogenesis. 1997 May;18(5):1085-92.

PMID:
9163700
12.

Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesis.

Kadlubar F, Kaderlik RK, Mulder GJ, Lin D, Butler MA, Teitel CH, Minchin RF, Ilett KF, Friesen MD, Bartsch H, et al.

Princess Takamatsu Symp. 1995;23:207-13.

PMID:
8844812
14.

Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues.

Kaderlik KR, Minchin RF, Mulder GJ, Ilett KF, Daugaard-Jenson M, Teitel CH, Kadlubar FF.

Carcinogenesis. 1994 Aug;15(8):1703-9.

PMID:
8055652
15.

Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes.

Kaderlik KR, Mulder GJ, Turesky RJ, Lang NP, Teitel CH, Chiarelli MP, Kadlubar FF.

Carcinogenesis. 1994 Aug;15(8):1695-701.

PMID:
8055651
16.

Expression of monomorphic and polymorphic N-acetyltransferases in human colon.

Ilett KF, Ingram DM, Carpenter DS, Teitel CH, Lang NP, Kadlubar FF, Minchin RF.

Biochem Pharmacol. 1994 Mar 2;47(5):914-7.

PMID:
8135868
17.

N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells.

Minchin RF, Reeves PT, Teitel CH, McManus ME, Mojarrabi B, Ilett KF, Kadlubar FF.

Biochem Biophys Res Commun. 1992 Jun 30;185(3):839-44.

PMID:
1627140
18.

Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites.

Butler MA, Lang NP, Young JF, Caporaso NE, Vineis P, Hayes RB, Teitel CH, Massengill JP, Lawsen MF, Kadlubar FF.

Pharmacogenetics. 1992 Jun;2(3):116-27.

PMID:
1306111
19.

Direct O-acetylation of N-hydroxy arylamines by acetylsalicylic acid to form carcinogen-DNA adducts.

Minchin RF, Ilett KF, Teitel CH, Reeves PT, Kadlubar FF.

Carcinogenesis. 1992 Apr;13(4):663-7.

PMID:
1576718
20.

Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon.

Turesky RJ, Lang NP, Butler MA, Teitel CH, Kadlubar FF.

Carcinogenesis. 1991 Oct;12(10):1839-45.

PMID:
1934265
21.

Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl.

Kadlubar FF, Dooley KL, Teitel CH, Roberts DW, Benson RW, Butler MA, Bailey JR, Young JF, Skipper PW, Tannenbaum SR.

Cancer Res. 1991 Aug 15;51(16):4371-7.

22.

Determination of carcinogenic arylamine N-oxidation phenotype in humans by analysis of caffeine urinary metabolites.

Kadlubar FF, Talaska G, Butler MA, Teitel CH, Massengill JP, Lang NP.

Prog Clin Biol Res. 1990;340B:107-14. No abstract available.

PMID:
2392442
23.

Verification of pentobarbital induced sedation by a new real time method of EEG computer analysis.

Lim AJ, Kott KS, Teitel CH, Winters WD.

Proc West Pharmacol Soc. 1978;21:31-5. No abstract available.

PMID:
693512

Supplemental Content

Loading ...
Support Center